NCT05694676

Brief Summary

Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

February 17, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2023

Completed
Last Updated

December 8, 2023

Status Verified

December 1, 2023

Enrollment Period

8 months

First QC Date

January 12, 2023

Last Update Submit

December 7, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Relationship Between Prenatal Maternal Anxiety and the Quality of General Movements

    Univariate statistical analyses will be performed to calculate differences in mothers' STAI-T scores between children with normal and abnormal GMs.

    3-5 months

  • Relationship Between Prenatal Maternal Depression and the Quality of General Movements

    Univariate statistical analyses will be performed to calculate differences in mothers' BDI scores between children with normal and abnormal GMs.

    3-5 months

Secondary Outcomes (1)

  • Multivariate analyses will be carried out with control variables

    3-5 months

Study Arms (2)

Mothers

Mothers aged 18 to 40 years, who have singleton pregnancy.

Other: State-Trait Anxiety Inventory-Trait, (STAI-T)Other: Beck Depression Inventory, (BDI)

Infants

Infants were born at 36-42 weeks of gestation without complication.

Other: Assessment of the quality of Genaral Movements (GMs)

Interventions

The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.

Also known as: Prechtl's General movements (GMs)
Infants

The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).

Mothers

BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression

Mothers

Eligibility Criteria

Age10 Weeks - 20 Weeks
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Mothers aged 18 to 40 years, who have singleton pregnancy. Infants were born at 36-42 weeks of gestation without complication.

You may qualify if:

  • Mothers aged 18 to 40 years,
  • Singleton pregnancy
  • No smoking during prengnancy
  • No illicit drug or alcohol use during pregnancy,
  • No major health conditions requiring invasive treatments (e.g., dialysis, blood transfusions, chemotherapy),
  • No diagnosis of psychotic illnesses (eg, schizophrenia,bipolar or borderline personality disorder), and
  • No major autoimmune diseases
  • No pregnancy-related complications: (including prenatal infection, pregnancy-included hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm labor, vaginal bleeding, placenta previa, or anemia).
  • infants were born at 36-42 wk of gestation
  • uncomplicated singleton birth,
  • no pre-existing neurologic conditions or major head trauma, neonatal intensive care unit stay limited to observation only (ie, no interventions), and
  • infant discharged from the hospital with the mother.

You may not qualify if:

  • post partum depression and/or anxiety
  • delivery complication
  • infant birth before 36 weeks gestation
  • infant weight lower 2500gr at birth
  • Apgar score 0f \<7 at 5 minutes
  • Major neonatal complications
  • Identified neurologic, genetic or congenital syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karaman Training and Research Hospital

Karaman, 70200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Aynur Basaran, MD,Prof

    Karaman Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Prof

Study Record Dates

First Submitted

January 12, 2023

First Posted

January 23, 2023

Study Start

February 17, 2023

Primary Completion

October 11, 2023

Study Completion

October 11, 2023

Last Updated

December 8, 2023

Record last verified: 2023-12

Locations